Max Rady College of Medicine
Term: Angiotensin Converting Enzyme (ACE) Inhibitor Use
Glossary Definition
Last Updated: 2006-02-15
Definition:
The percentage of residents who received at least one prescription for ACE Inhibitors (ATC codes C09A, C09B) in 2003/04. The primary use of ACE inhibitors is to lower blood pressure. Values are adjusted to reflect the total population of Manitoba (males and females combined).
Related terms
- Anatomical Therapeutic Chemical (ATC) Drug Classification System
- Angiotensin Converting Enzyme Inhibitors (ACEIs)
- Angiotensin II Receptor Blockers (ARB)
References
- Fransoo R, Martens P, The Need to Know Team, Burland E, Prior H, Burchill C, Chateau D, Walld R. Sex Differences in Health Status, Health Care Use, and Quality of Care: A Population-Based Analysis for Manitoba's Regional Health Authorities. Winnipeg, MB: Manitoba Centre for Health Policy, 2005. [Report] [Summary] [Additional Materials] (View)
Request information in an accessible format
If you require access to our resources in a different format, please contact us:
- by phone at 204-789-3819
- by email at info@cpe.umanitoba.ca
We strive to provide accommodations upon request in a reasonable timeframe.
Contact us
Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine,
Rady Faculty of Health Sciences,
Room 408-727 McDermot Ave.
University of Manitoba
Winnipeg, MB R3E 3P5 Canada
204-789-3819